Cortex IDX EA MT5 combines US30 trend following with pullback entries and one-position management. Its public signal shows a strong accumulated result, but the market mix, drawdown and size of losing trades deserve attention. This review explains the strategy, examines genuine MQL5 evidence and weighs the customer feedback. We have not independently traded or backtested this EA.
View Cortex IDX EA MT5 features & $249.95 pricing →

How Cortex IDX approaches US30
The official product listing describes a trend-following system that enters on pullbacks. It keeps one position open at a time and does not use grid, martingale or averaging. That makes the exposure easier to understand than a recovery basket, although it does not make an individual position risk-free.
Profit exits can use a trailing stop or an optional fixed take profit. Losing trades can close when an opposite M1 signal appears. The practical distinction is important: a signal-based exit depends on when that signal occurs and how the order is executed. It should not be described as a guaranteed small loss or a universal fixed cash-risk limit.
The listing permits any chart timeframe. M1 refers to the internal opposite-signal analysis, not a requirement to display every chart on M1.
The public signal: what the figures show
Captured 10 September 2026 from the Cortex IDX MQL5 signal. MQL5 labels it a Real Account on RoboForex-ECN, with 1:300 leverage. This is the platform’s classification, not our independent audit of broker statements.
| Growth / net profit | 100.17% / $481.52 |
|---|---|
| Closed trades | 119: 113 winners (94.95%) and 6 losers. |
| Profit factor | 5.02 |
| Average win / loss | $5.32 / −$19.96 |
| Relative drawdown | 6.11% by balance; 16.69% by equity. |
| Maximum deposit load | 47.56%; a historical margin-load measure, not a loss limit. |
| Cash flows | $500 initial deposit, $150 later deposits, $670 withdrawals and $461.52 balance/equity. |

The accumulated result and profit factor are positive features of this snapshot. However, the average loser was about 3.75 times the average winner. A system can produce many small wins and still be sensitive to a cluster of larger losses. The captured worst trade was −$39.84, and its longest losing sequence comprised three trades totalling −$57.46.
Why the account is not a clean US30-only test

The distribution contains 84 US30 trades, 20 US Tech trades and 15 DE40 trades. US30 contributed $469.94 net profit, US Tech $24.82 and DE40 −$13.24. The combined headline return therefore describes this account’s mix, rather than proving the outcome of trading only today’s US30 product.
The page contains approximately 14 weeks of account history, including activity before the product’s 7 August 2026 publication. Its Started field reads 5 September 2026, while older journal entries are also present. We cannot establish identical observation periods for every series from this public view. Nor can we attribute all historical trades to the current release.
The 16.69% equity drawdown also deserves more attention than the smaller balance figure alone. Open-position losses matter even before trades close. Maximum deposit load measures margin usage, so its 47.56% reading must not be substituted for drawdown or treated as a recommended setting.
What MQL5 customers say
The product page displayed eight reviews and a 4.0 rating when checked. Feedback includes praise for setup, support and performance, but it is mixed. These are customers’ observations, not independently verified test results.

BattyEkbua’s positive September comment praises ease of setup and support, while explicitly planning a later update after a longer trial. Yik Hung Lai describes an intention to test the revised product on a small live account. Both are useful context, but neither establishes a long forward record for the latest build.
Mike’s September criticism questions whether historical testing translates to live results. Alexander Seidel also reports dissatisfaction with losses and the difference between testing and live trading. Those concerns should be taken seriously as buyer feedback, without presenting overfitting as a proven finding.
The developer’s replies point to release changes and the need to match the tested version, date range and tick data. That is a reason to reproduce a test carefully, not evidence that perfect backtest/live agreement is guaranteed. Broker quotes, spread, slippage and execution can still differ.
Version changes and the tests worth doing
The release history records algorithm revisions on 2 and 4 September 2026; the checked listing showed version 2.20. The notes are brief and do not document every changed condition. Treat earlier screenshots and customer experiences as dated evidence, rather than assuming they describe the exact current algorithm.
No separate public product manual was linked from the main listing when checked. Its operating guidance recommends real-tick testing on the intended broker, with particular attention to the recent year. A recent sample is useful, but a broader range of market conditions and forward observation give a stronger basis for judging consistency.
- Check US30 contract specifications. Minimum lot, tick value, margin and spread can differ substantially between brokers. The developer’s $100 starting reference is not a universal suitable balance.
- Identify the exit mode. Trailing profit and fixed take profit can produce different trade profiles. Match the settings when comparing results.
- Inspect losing trades. Review the time and loss before an opposite-signal exit, rather than judging the system only by its winning percentage.
- Compare like with like. Use the same EA build, dates and parameters, then compare actual fills and costs. Do not assume an older multi-index account reproduces today’s US30 setup.
- Observe execution. ECN / RAW conditions and low spreads are the developer’s recommendation; the account label alone does not prove every broker will behave similarly.
Cortex IDX versus Cortex Aurex
CheaperForex also offers Cortex Aurex EA MT5, Vladimir Mametov’s gold-focused product. The first decision is the market you want to trade: US30 for IDX or gold for Aurex. Read our Cortex Aurex review for its separate evidence and operating details.
Do not transfer performance claims between them or assume different instrument names guarantee diversification. Compare actual trade timing and combined drawdowns if you intend to run both.
Our assessment
Cortex IDX has a clear appeal for traders seeking a focused US30 system with single-position exposure and understandable exit choices. The linked record gives buyers something substantive to examine, while the mixed reviews and larger average losses identify what needs testing. At $249.95, assess the strategy and current broker behaviour rather than buying solely on the headline growth percentage. Historical results cannot guarantee future returns.
Cortex IDX review FAQs
Is the Cortex IDX signal a US30-only track record?
No. The 10 September 2026 snapshot contained 84 US30 trades, 20 US Tech trades and 15 DE40 trades. The current product is presented as a US30 EA, so the combined account should not be treated as an isolated US30 test.
Does a high win rate mean the losses are small?
No. In the captured record, the average loss was $19.96 compared with an average win of $5.32. Win rate needs to be read alongside loss size, drawdown and trading costs.
Is M1 the required chart timeframe?
The current listing allows any chart timeframe while identifying M1 for the internal opposite-signal loss exit. These are separate aspects of the strategy.
How is Cortex IDX different from Cortex Aurex?
Cortex IDX is presented for US30 index trading; Cortex Aurex is the same developer’s gold-focused EA. Their results and settings should be assessed separately, and owning both does not automatically diversify risk.